Showing results (501-510 of 1,079) with videos related to
Sort By:
Pageof 108
International Journal of Clinical Practice|January 19, 2007
Effect of sitaxsentan treatment on quality of life in pulmonary arterial hypertensionR Souza, B C S Martins, C Jardim, et al.Nutrition (Burbank, Los Angeles County, Calif.)|June 15, 2010
β-Hydroxy-β-methylbutyrate modifies human peripheral blood mononuclear cell proliferation and cytokine production in vitroEverson A Nunes, Amy R Lomax, Paul S Noakes, et al.Anatomia, Histologia, Embryologia|April 27, 2013
Efficiency of the spermatogenesis in zebu bulls (Bos taurus indicus)P A T Andreussi, D S Costa, F J C Faria, et al.Journal of the American Society for Mass Spectrometry|September 21, 2012
Mass spectrometry parameters optimization for the 46 multiclass pesticides determination in strawberries with gas chromatography ion-trap tandem mass spectrometryVirgínia C Fernandes, Jose L Vera, Valentina F Domingues, et al.Journal of Veterinary Internal Medicine|January 28, 2010
Platelet-activating factor and evidence of oxidative stress in the bronchoalveolar fluid of Thoroughbred colts during race trainingP V Michelotto, L A Muehlmann, A L Zanatta, et al.Arthritis and Rheumatism|September 1, 1996
Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expressionJ P Caron, J C Fernandes, J Martel-Pelletier, et al.The Biochemical Journal|August 5, 1999
Homologous xylanases from Clostridium thermocellum: evidence for bi-functional activity, synergism between xylanase catalytic modules and the presence of xylan-binding domains in enzyme complexesA C Fernandes, C M Fontes, H J Gilbert, et al.Journal of Inherited Metabolic Disease|May 20, 2005
Clinical response to sildenafil in pulmonary hypertension associated with Gaucher diseaseC J C Fernandes, C Jardim, L A S Carvalho, et al.Osteoarthritis and Cartilage|March 1, 2002
Peroxisome proliferator-activated receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1H Fahmi, J-P Pelletier, J A Di Battista, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 23, 2006
Human metabolism of nebicapone (BIA 3-202), a novel catechol-o-methyltransferase inhibitor: characterization of in vitro glucuronidationA I Loureiro, M J Bonifácio, C Fernandes-Lopes, et al.Pageof 108